MYRIAD GENETICS INC 4
4 · MYRIAD GENETICS INC · Filed Mar 27, 2009
Insider Transaction Report
Form 4
Laslie W Wayne
Chief Operating Officer, MPI
Transactions
- Sale
Common Stock
2009-03-27$44.96/sh−24,000$1,079,040→ 15,082 total - Exercise/Conversion
Common Stock
2009-03-27$9.75/sh+24,000$234,000→ 39,082 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2009-03-27−24,000→ 23,744 totalExercise: $9.75Exp: 2014-11-11→ Common Stock (24,000 underlying)
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.